Literature DB >> 18092941

Mitofusin 2: a mitochondria-shaping protein with signaling roles beyond fusion.

Olga Martins de Brito1, Luca Scorrano.   

Abstract

Mitochondria are central organelles in metabolism, signal transduction, and programmed cell death. To meet their diverse functional demands, their shape is strictly regulated by a growing family of proteins that impinge on fission and fusion of the organelle. Mitochondrial fusion depends on Mitofusin (Mfn) 1 and 2, two integral outer-membrane proteins. Although MFN1 seems primarily involved in the regulation of the docking and fusion of the organelle, mounting evidence is implicating MFN2 in multiple signaling pathways not restricted to the regulation of mitochondrial shape. Here we review data supporting a role for this mitochondria-shaping protein beyond fusion, in regulating mitochondrial metabolism, apoptosis, shape of other organelles, and even progression through cell cycle. In conclusion, MFN2 appears a multifunctional protein whose biologic function is not restricted to the regulation of mitochondrial shape.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092941     DOI: 10.1089/ars.2007.1934

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  58 in total

Review 1.  Mitochondrial shape changes: orchestrating cell pathophysiology.

Authors:  Silvia Campello; Luca Scorrano
Journal:  EMBO Rep       Date:  2010-08-20       Impact factor: 8.807

Review 2.  Mitochondrial morphology and cardiovascular disease.

Authors:  Sang-Bing Ong; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2010-07-14       Impact factor: 10.787

3.  MFN2 ameliorates cell apoptosis in a cellular model of Parkinson's disease induced by rotenone.

Authors:  Yang Yang; Liu-Jun Xue; Xiao Xue; Zhou Ou; Teng Jiang; Ying-Dong Zhang
Journal:  Exp Ther Med       Date:  2018-08-10       Impact factor: 2.447

Review 4.  Mitochondrial dynamics in cardiovascular health and disease.

Authors:  Sang-Bing Ong; Andrew R Hall; Derek J Hausenloy
Journal:  Antioxid Redox Signal       Date:  2012-09-10       Impact factor: 8.401

Review 5.  Mitochondrial quality control and dynamics in Parkinson's disease.

Authors:  Melissa K McCoy; Mark R Cookson
Journal:  Antioxid Redox Signal       Date:  2011-07-07       Impact factor: 8.401

6.  Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death.

Authors:  Alejandro Martorell-Riera; Marc Segarra-Mondejar; Juan P Muñoz; Vanessa Ginet; Jordi Olloquequi; Jeús Pérez-Clausell; Manuel Palacín; Manuel Reina; Julien Puyal; Antonio Zorzano; Francesc X Soriano
Journal:  EMBO J       Date:  2014-08-21       Impact factor: 11.598

7.  MiR-106b-mediated Mfn2 suppression is critical for PKM2 induced mitochondrial fusion.

Authors:  Haili Wu; Zhuoyu Li; Yingying Wang; Peng Yang; Zongrui Li; Hanqing Li; Changxin Wu
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

8.  Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease.

Authors:  Giorgia Bergamin; Francesca Boaretto; Chiara Briani; Elena Pegoraro; Mario Cacciavillani; Andrea Martinuzzi; Maria Muglia; Andrea Vettori; Giovanni Vazza; Maria Luisa Mostacciuolo
Journal:  Neuromolecular Med       Date:  2014-05-13       Impact factor: 3.843

Review 9.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

10.  Mitofusin2 decreases intracellular cholesterol of oxidized LDL-induced foam cells from rat vascular smooth muscle cells.

Authors:  Chao He; Ying Chen; Chun Liu; Ming Cao; Yu-Jin Fan; Xiao-Mei Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.